<SEC-DOCUMENT>0001513162-18-000056.txt : 20180305
<SEC-HEADER>0001513162-18-000056.hdr.sgml : 20180305
<ACCEPTANCE-DATETIME>20180305080014
ACCESSION NUMBER:		0001513162-18-000056
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180305
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180305
DATE AS OF CHANGE:		20180305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ITUS Corp
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37492
		FILM NUMBER:		18664437

	BUSINESS ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118
		BUSINESS PHONE:		310-484-5200

	MAIL ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>Form 8K</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>UNITED STATES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Washington, D.C. 20549</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>FORM 8-K</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>CURRENT REPORT</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Date of Report (Date of earliest event reported):&nbsp; March 5, 2018</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'></font></u></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>ITUS CORPORATION</font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(Exact name of registrant as specified in its charter)</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=194 style="WIDTH:145.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Delaware</font></b></p></td> <td width=175 style="WIDTH:130.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>000-11254</font></b></p></td> <td width=170 style="WIDTH:127.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>11-2622630</font></b></p></td></tr> <tr> <td width=194 style="WIDTH:145.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(State or other jurisdiction<br>of incorporation)</font></p></td> <td width=175 style="WIDTH:130.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(Commission<br>File Number)</font></p></td> <td width=170 style="WIDTH:127.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(IRS Employer</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Identification No.)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=349 style="WIDTH:261.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"' lang=FR>3150 Almaden Expressway, Suite 250</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"' lang=FR>San Jose, CA</font></b></p></td> <td width=337 style="WIDTH:252.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"' lang=FR>95118</font></b></p></td></tr> <tr> <td width=349 style="WIDTH:261.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(Address of principal executive offices)</font></p></td> <td width=337 style="WIDTH:252.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(Zip Code)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Registrant&#146;s telephone number, including area code:&nbsp; <b>(408) 708-9808</b></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  MARGIN:0in 0in 0pt'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>(Former name or former address, if changed since last report)</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman";  TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'></font></u></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><a name=up><font style=FONT-SIZE:11pt>Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions: </font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=Check1 /><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;<font face=Wingdings>o</font>&nbsp;&nbsp;&nbsp; Written communications pursuant to Rule&nbsp;425 under the Securities Act (17&nbsp;CFR&nbsp;230.425)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=Check2 /><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;<font face=Wingdings>o</font>&nbsp;&nbsp;&nbsp; Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17&nbsp;CFR&nbsp;240.14a-12)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=Check3 /><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;<font face=Wingdings>o</font>&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17&nbsp;CFR&nbsp;240.14d-2(b))</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=Check4 /><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;<font face=Wingdings>o</font>&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17&nbsp;CFR&nbsp;240.13e-4(c))</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt>&nbsp;Emerging growth company&nbsp; <font face=Wingdings>o</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp; <font face=Wingdings>o</font> </font></p></div><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'></font> <div style=page:WordSection2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>1</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Events</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>On March 5, 2018, ITUS Corporation issued a press release announcing the formation of a strategic alliance with Serametrix Corporation. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Item 9.01 Financial Statements and Exhibits.</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>(d) Exhibits</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>The following exhibits are filed with this Current Report on Form 8-K:</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>Exhibit No.&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Description</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></pre><pre style="FONT-SIZE:11pt; FONT-FAMILY:Times New Roman; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style='FONT-FAMILY:"Times New Roman","serif"'>99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press Release dated March 5, 2018</font></pre> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>2</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%'><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>SIGNATURES</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">Dated: March 5, 2018</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">ITUS CORPORATION</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">By:</font></p></td> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">/s/ Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">Name: Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; COLOR:black">Title: President and Chief Executive Officer</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%' align=center><font style="FONT-SIZE:11pt; LINE-HEIGHT:107%">3</font></p></div></body>
<!-- EDGAR Validation Code: 0E834C3C -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>Exhibit99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<head><title>Exhibit 99.1</title> </head> <body vlink=#954f72 link=blue lang=EN-US> <div style=page:WordSection1><b> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center> <table bordercolor=transparent cellspacing=0 align=right> <tr> <td> <p align=right><strong>Exhibit 99.1</strong></p></td></tr></table></p></b> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><b><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>ITUS Corporation Forms Alliance with Serametrix Corporation</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>SAN JOSE, CA &#150; March 5, 2018:</font></b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>&nbsp;</font><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>ITUS Corporation <font size=+0>(NASDAQ: ITUS)</font> today announced that ITUS and Serametrix Corporation have signed an agreement to bring the power of Cchek&#153;, ITUS&#146;s proprietary, AI-driven liquid biopsy cancer diagnostic technology to Serametrix&#146;s substantial expertise in immune monitoring assays. &nbsp;</font><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"'>Serametrix flow cytometry and related data analysis services are already widely used in immunotherapy drug trials. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>Dr. Amit Kumar, ITUS's Chairman and CEO, stated, "There is potential for tremendous synergy from the complementary expertise of ITUS and Serametrix. &nbsp;We believe that the additional capabilities provided by the Serametrix alliance will allow ITUS Corporation to expand the commercial opportunities of Cchek&#153;. &nbsp;Also, we believe that the application of our artificial intelligence expertise to Serametrix&#146;s flow cytometry immuno-profiling services will allow Serametrix to offer unique and superior capabilities unavailable to other laboratories.&#148; &nbsp;Dr. Kumar continued, &#147;As we develop our early cancer detection diagnostic, we expect this collaboration will create additional exposure of our technology to potential corporate partners.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>Henry Hepburne-Scott, VP of Business Development of Serametrix, said, &#147;We are delighted to enter into this agreement with ITUS as our respective technologies and capabilities are highly complementary.&nbsp; In particular, we believe that the application of ITUS artificial intelligence will add value to our unique and proprietary MDSC monitoring technology and we are looking forward to exploring novel opportunities with our extensive network of academic and commercial partners.&#148; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><b><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN>Serametrix Corporation</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN>Serametrix provides solutions to the problem of monitoring immune response to immunotherapies in clinical trial cancer patients. &nbsp;In partnership with the Ludwig Institute for Cancer Research (LICR) and other leading institutes Serametrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies. &nbsp;Serametrix is part owned by the LICR.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><b><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN>ITUS Corporation</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><u><font style='FONT-FAMILY:"Arial","sans-serif"; COLOR:#3333ff'>ITUS</font></u><font style='FONT-FAMILY:"Arial","sans-serif"'>, a cancer-focused biotechnology company, is harnessing the body&#146;s immune system in the </font><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN>fight against cancer. &nbsp;Its wholly owned subsidiary, Anixa Diagnostics Corporation, is developing the Cchek</font><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN>&#153;</font><font style='FONT-FAMILY:"Arial","sans-serif"' lang=EN> platform, a series of non-invasive blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy. &nbsp;Its majority owned subsidiary, Certainty Therapeutics, Inc., is developing CAR-T based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. &nbsp;ITUS also continually examines emerging technologies in complementary or related fields for further development and commercialization. &nbsp;</font><font style='FONT-FAMILY:"Arial","sans-serif"'>Additional information is available at <u><font style=COLOR:#3333ff>www.ITUScorp.com</font></u>.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Arial","sans-serif"'>###</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><i><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN>Forward-Looking Statements:</font></i></b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN> Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 5.8pt 0pt 0.1pt; LINE-HEIGHT:107%; TEXT-INDENT:-0.05pt'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Breuer Text"; COLOR:#00457d; LINE-HEIGHT:107%'>ITUS <font style=LETTER-SPACING:-0.05pt>Corporation:</font> FOCUSED ON <font style=LETTER-SPACING:-0.15pt>INNOVATION&#153;</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:107%'><font style='FONT-FAMILY:"Arial","sans-serif"'>Company contact:</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:107%'><font style='FONT-FAMILY:"Arial","sans-serif"'>Mike Catelani</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:107%'><font style='FONT-FAMILY:"Arial","sans-serif"'>(408) 708-9808</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:107%'><u><font style='FONT-FAMILY:"Arial","sans-serif"; COLOR:#3333ff'>MCatelani@ITUScorp.com</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:107%'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Arial","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 2B5B8197 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
